A miRNA181a/NFAT5 axis links impaired T cell tolerance induction with autoimmune type 1 diabetes
Serr I, Scherm MG, Zahm AM, Schug J, Flynn VK, Hippich M, Kälin S, Becker M, Achenbach P, Nikolaev A, Gerlach K, Liebsch N, Loretz B, Lehr CM, Kirchner B, Spornraft M, Haase B, Segars J, KĂ¼per C, Palmisano R, Waisman A, Willis RA, Kim ...
The miR-21/PDCD4/AP-1 feedback loop function as a driving force for renal fibrogenesis
Sun Q, Miao J, Luo J, Yuan Q, Cao H, Su W, Zhou Y, Jiang L, Fang L, Dai C, Zen K, Yang J. J Cell Sci. 2018 Jan 19. pii: jcs.202317. PubMed
MicroRNA-149-5p regulates blood-brain barrier permeability after transient middle cerebral artery occlusion in rats by targeting S1PR2 of pericytes
Wan Y, Jin HJ, Zhu YY, Fang Z, Mao L, He Q, Xia YP, Li M, Li Y, Chen X, Hu B. FASEB J. 2018 Jan 18:fj201701121R. PubMed
Design and implementation of a synthetic pre-miR switch for controlling miRNA biogenesis in mammals
Atanasov J, Groher F, Weigand JE, Suess B. Nucleic Acids Res. 2017 Dec 15;45(22):e181. PubMed
Personalized RNA-medicine for pancreatic cancer
Gilles ME, Hao L, Huang L, Rupaimoole R, Lopez-Casas PP, Pulver E, Jeong JC, Muthuswamy SK, Hidalgo M, Bhatia SN, Slack FJ. Clin Cancer Res. 2018 Jan 12. pii: clincanres.2733.2017. PubMed
Amphiphilic nanocarrier-induced modulation of PLK1 and miR-34a leads to improved therapeutic response in pancreatic cancer
Gibori H, Eliyahu S, Krivitsky A, Ben-Shushan D, Epshtein Y, Tiram G, Blau R, Ofek P, Lee JS, Ruppin E, Landsman L, Barshack I, Golan T, Merquiol E, Blum G, Satchi-Fainaro R. Nat Commun. 2018 Jan 2;9(1):16. PubMed
Helix-7 in Argonaute2 shapes the microRNA seed region for rapid target recognition
Klum SM, Chandradoss SD, Schirle NT, Joo C, MacRae IJ. EMBO J. 2018 Jan 4;37(1):75-88. PubMed
The Role of micro RNAs in Breast Cancer Metastasis: Preclinical Validation and Potential Therapeutic Targets
Weidle UH, Dickopf S, Hintermair C, Kollmorgen G, Birzele F, Brinkmann U. Cancer Genomics Proteomics. 2018 Jan-Feb;15(1):17-39. PubMed